Literature DB >> 15276142

Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs.

Douglas Labar1.   

Abstract

PURPOSE: To study, in patients on unchanged antiepileptic drugs (AEDs): (1) seizure rates after 3 and 12 months of vagus nerve stimulation (VNS); (2) effects of VNS parameters; (3) patient characteristics versus VNS responsiveness.
METHODS: We located in the VNS registry 269 patients treated for 1 year with no changes in AEDs. Seizure rates were calculated at 3 and 12 months. We analyzed: (1) 3 months versus 12 months seizure rates; (2) effects of changing duty cycles between 3 and 12 months; (3) effects of output current; (4) seizure rate changes associated with patient characteristics.
RESULTS: Seizure rates improved between 3 months (median = -45%) and 12 months (median = -58%) (P < 0.0001). There were no differences between patients who stayed on standard or rapid cycling, or changed from standard to rapid. Stimulation parameters did not affect seizure rates. VNS responsiveness was associated with older age (P = 0.016), longer duration epilepsy (P = 0.033), and syndromes other than Lennox-Gastaut (P = 0.003).
CONCLUSIONS: This was an analysis of treatment outcomes, not a prospective clinical trial. Nonetheless, our results suggest: (1) seizure rates decline with increasing VNS duration; (2) this decline occurs without AED changes; (3) this decline is not due to changes in stimulation parameters; (4) patient characteristics predictive of VNS responsiveness remain elusive. Copyright 2003 BEA Treading Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276142     DOI: 10.1016/j.seizure.2003.09.009

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  25 in total

1.  Vagus nerve stimulation: predictors of seizure freedom.

Authors:  J Janszky; M Hoppe; F Behne; I Tuxhorn; H W Pannek; A Ebner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

2.  Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran.

Authors:  Hossein Pakdaman; Ali Amini Harandi; Mehdi Abbasi; Mohammad Karimi; Mohammad Ali Arami; Seyed Ali Mosavi; Karim Haddadian; Omidvar Rezaei; Sohrab Sadeghi; Guive Sharifi; Koroush Gharagozli; Parviz Bahrami; Farzad Ashrafi; Hosein Delavar Kasmae; Amirhossein Ghassemi; Mehran Arabahmadi; Behdad Behnam
Journal:  Neurol Sci       Date:  2016-07-11       Impact factor: 3.307

3.  Vagus Nerve Stimulation Applied with a Rapid Cycle Has More Profound Influence on Hippocampal Electrophysiology Than a Standard Cycle.

Authors:  Lars E Larsen; Wytse J Wadman; Daniele Marinazzo; Pieter van Mierlo; Jean Delbeke; Sofie Daelemans; Mathieu Sprengers; Lisa Thyrion; Wouter Van Lysebettens; Evelien Carrette; Paul Boon; Kristl Vonck; Robrecht Raedt
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

4.  Vagus Nerve Stimulation: Rapid versus Slow Cycling in a Laboratory Model.

Authors:  Robert S Fisher
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  Should I offer vagus nerve stimulation as part of my neurology practice?

Authors:  Kai M Denski; David M Labiner
Journal:  Neurol Clin Pract       Date:  2014-08

6.  Meta-analysis of vagus nerve stimulation treatment for epilepsy: correlation between device setting parameters and acute response.

Authors:  S Ghani; J Vilensky; B Turner; R S Tubbs; M Loukas
Journal:  Childs Nerv Syst       Date:  2015-10-22       Impact factor: 1.475

Review 7.  Vagus nerve stimulation for epilepsy and depression.

Authors:  Andrew H Milby; Casey H Halpern; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

8.  VEP indices of cortical lateral interactions in epilepsy treatment.

Authors:  Mary M Conte; Jonathan D Victor
Journal:  Vision Res       Date:  2008-06-24       Impact factor: 1.886

9.  Efficacy of vagus nerve stimulation in brain tumor-associated intractable epilepsy and the importance of tumor stability.

Authors:  Kunal S Patel; Nelson Moussazadeh; Werner K Doyle; Douglas R Labar; Theodore H Schwartz
Journal:  J Neurosurg       Date:  2013-04-19       Impact factor: 5.115

10.  Efficacy of vagus nerve stimulation as a treatment for medically intractable epilepsy in brain tumor patients. A case-controlled study using the VNS therapy Patient Outcome Registry.

Authors:  Kunal S Patel; Douglas R Labar; Charles M Gordon; Kevin H Hassnain; Theodore H Schwartz
Journal:  Seizure       Date:  2013-06-12       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.